fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Advertisment

EuLITE: high cut-off haemodialysis doesn’t improve outcomes in myeloma cast nephropathy. Dr Mark Cook (University Hospitals Birmingham, UK) discusses the results of the EuLITE trial looking at free light chain removal by extended haemodialysis in cast nephropathy.

Written by | 21 Jul 2016 | All Medical News

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.